Header Logo

Connection

VICTOR RIVERA to Bone Neoplasms

Back to Details
This is a "connection" page, showing publications VICTOR RIVERA has written about Bone Neoplasms.
VICTOR RIVERA
Connection Strength
0.061
Bone Neoplasms
  1. Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas. J Clin Oncol. 2012 01 01; 30(1):78-84.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.